<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53494">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02409784</url>
  </required_header>
  <id_info>
    <org_study_id>13-214</org_study_id>
    <nct_id>NCT02409784</nct_id>
  </id_info>
  <brief_title>PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis</brief_title>
  <official_title>PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Regional brain glucose hypometabolism occurs during aging and may contribute to the onset of
      aging-related cognitive impairment in humans. Ketones are the main alternative energy
      substrate to glucose for the brain. Several studies show that brain ketone uptake and
      metabolism are unaltered in cognitively-normal older persons and in Alzheimer's disease
      (AD). Nutritional ketosis is reported to have a positive impact on cognitive performances in
      mild cognitive impairment and AD. Nevertheless, changes in regional brain glucose and ketone
      uptake in adults are poorly understood during diet-induced experimental ketosis. The
      investigators hypothesis was that during diet-induced ketosis, brain ketone uptake would be
      directly correlated with the elevation of blood ketone levels and inversely correlated to
      brain glucose uptake.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in cerebral metabolic rate of acetoacetate after 4 days of ketogenic diet</measure>
    <time_frame>At baseline (approximatively 1 month before the onset of the diet) and right after a 4 days ketogenic diet</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in cerebral metabolic rate of glucose after 4 days of ketogenic diet</measure>
    <time_frame>At baseline (approximatively 1 month before the onset of the diet) and right after a 4 days ketogenic diet</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>TEP study without any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketogenic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TEP study with a 4 days ketogenic diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketogenic diet</intervention_name>
    <description>4 days 4:1 (lipids:protein/carbohydrates) ketogenic diet</description>
    <arm_group_label>Ketogenic diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults

          -  No signs of cognitive impairment

        Exclusion Criteria:

          -  Not within the age limits

          -  Pregnancy or breast feeding

          -  Incapacity to withstand a supine position for 40 min

          -  Non lacunar infarction

          -  Known psychiatric history of schizophrenia, psychotic disorders, major affective
             disorders (bipolar disorder and major depression &lt;5 years), panic disorder, obsessive
             compulsive disorders and other conditions that may affect memory

          -  Epilepsy, brain trauma with loss of consciousness, subarachnoid hemorrhage

          -  History of alcool and/or substances abuse (excessive alcool consumption ≥10
             drinks/weeks)

          -  Parkinson disease

          -  Down syndrome

          -  Inflammatory disease

          -  Abnormal blood pressure, liver or kidney function, blood count

          -  Dyslipidemia, hypothyroidism, osteoporosis

          -  Presence of a metal object in the body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen C Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 1, 2015</lastchanged_date>
  <firstreceived_date>March 27, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Brain metabolism</keyword>
  <keyword>Ketones</keyword>
  <keyword>Ketogenic diet</keyword>
  <keyword>TEP scan</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
